ABSTRACT The contractile effects of neurotensin (NT) and cholecystokinin octapeptide (CCK-8) on isolated circular smooth muscle strips of chicken gallbladder were investigated. The NT (0.25-300 nM) produced concentration-dependent contractions on smooth muscle with an EC 50 of 8.5 nM (95% confidence limits = 5.3-13.6 nM). In comparison, CCK-8 produced concentration-dependent contractions with an EC 50 of 13 nM (95% confidence limits of 9-20 nM). There were no statistical differences in contractile responses when comparing NT and CCK-8 at equimolar concentrations. The NT appears to act directly on smooth muscle tissue in the chicken; the contractile responses were not blocked by 10 μM atropine or tetrodotoxin.
INTRODUCTION
The most effective hormonal stimulant of gallbladder evacuation in mammals is cholecystokinin (CCK). Indeed, both contraction and relaxation of the gallbladder correlate well with plasma concentrations of the peptide (Wiener et al., 1981) . Nevertheless, several other gut hormones influence the postprandial regulation of smooth muscle tension in the gallbladder. For example, the effects of CCK on guinea pig gallbladder are augmented by secretin and glucagon that by themselves have no contractile activity. Even though secretin and glucagon are structurally related to vasoactive intestinal polypeptide (VIP), contractions induced by CCK are decreased in the presence of VIP (Vagne and Troistkaja, 1976) . Similarly, VIP antagonizes the effects of CCK on gallbladder pressure in the opossum and by itself induces dose-related decreases in basal gallbladder pressure (Ryan and Cohen, 1977) . Gastrin has been shown to have only weak cholecystokinetic activity (Vagne and Grossman, 1968) . In muscle strips from human gallbladder tissue, motilin produced contractions, whereas pancreatic polypeptide induced gallbladder relaxation and inhibited biliary output (Greenberg et al., 1978; Pomerantz et al., 1983) .
Neurotensin (NT) is a biologically active tridecapeptide occurring in the central nervous system and the gastrointestinal (GI) tract of several species. It was originally isolated from extracts of bovine hypothalami (Carraway and Leeman, 1973) and the GI tract (Kitabgi et al., 1976; Carraway and Leeman, 1976b) . The majority of the total NT content is found in the intestinal tract (Carraway and Leeman, 1976b; Carraway et al., 1982) . The amino acid sequence is identical from both tissue sources: pGlu-Leu-Tyr-Glu-Asn-Lys-Pro-ArgArg-Pro-Tyr-Ile-Leu-OH Leeman, 1975, 1976a) . The presence of NT has been immunochemically identified in brain and gut tissue samples from all representative vertebrate classes (including birds) and some invertebrates (Carraway et al., 1982) . In all species examined, the biologically active carboxyl-terminus of the peptide is highly conserved.
A portion of the activity is mediated by extracellular calcium as 100 nM nifedipine inhibited 30% of peptideinduced muscle tension. The NT receptor (NTR) type 1 antagonist SR 48692 (0.1 μM) did not significantly reduce NT potency. The contractile effects of CCK-8 remained unaltered in tissues pretreated with atropine, TTX, or nifedipine. The CCK-A antagonist lorglumide, at a concentration of 1 μM, reduced the contractile potency of CCK-8 by one-half. Avian receptors for NT and CCK may differ pharmacologically from their mammalian counterparts, but their contractile actions on the gallbladder resulting in increased biliary output by flow are further evidence of their role in the postprandial regulation of lipid digestion in chickens.
Neurotensin is expressed in higher concentrations in the avian gut than in the mammalian gut (Carraway et al., 1982) . Enteroendocrine N-type cells, which release NT into the circulation, are diffusely distributed along the entire intestinal tract of chickens and are particularly numerous in the pylorus, the zone that adjoins the gizzard (Sundler et al., 1977) . In contrast, most of the N cells in mammalian intestine are present chiefly in the jejunum and ileum, and are very sparse in the duodenum (Orci et al., 1976; Helmstaedter et al., 1977; Polak et al., 1977; Sundler et al., 1977) .
The actions of avian intestinal NT indicate a role in the regulation of fat digestion in chickens. Neurotensin inhibits gastric motility and pepsin secretion (DeGolier et al., 1997) , increases pancreatic lipase activity (DeGolier et al., 1999) , and increases bile acid production and secretion (Gui et al., 2000) . As in mammalian species (Kalafatakis and Triantafyllou, 2011) , oleic acid has been shown to be a potent stimulus for the release of NT (DeGolier et al., 2013) .
To support the observation that NT acts like an enterogastrone, the potential cholecystogogue activity of NT warrants investigation. Thus, the objectives of this study were to 1) observe and quantify the contractile effects of NT on the smooth muscle contraction of the gallbladder (in vitro), 2) compare those contractile effects to those of the most effective hormonal stimulant of gallbladder evacuation, CCK, and 3) to investigate potential mechanisms underlying NT and CCK contractile activity in chickens.
MATERIALS AND METHODS

Birds
Single-Comb White Leghorn hens, 14-22 wk of age, were used in this study. Body weights ranged from 0.8 to 1.4 kg. The hens were housed in individual wire cages in environmentally controlled rooms maintained at 25°C. Relative humidity was kept between 40 and 50%, and photoperiod was controlled to provide 14 h of light from 0900 to 2300 h. All birds had access to water and a diet (all mash breeder ration: 16% protein, 4.5% CP, 3% crude fat, and 2,874 kcal/kg of ME) ad libitum prepared by the Department of Animal Sciences at the University of Minnesota. All procedures were in accordance with the policies of the University of Minnesota Institutional Animal Care and Use Committee.
Chicken Gallbladder
The longitudinal and circular muscle layers of chicken gallbladder are not easily distinguished, as the arrangement appears to vary with the degree of distention. The outer circular layer is the more defined layer, whereas the longitudinal layer is less obvious (Hodges, 1974) .
Unlike mammals, which have a single bile duct, chickens have 2 ducts that are connected intrahepatically (Hodges, 1974) . The left hepatic duct drains bile directly from the liver into the duodenum, and the right hepatic duct drains bile into a gallbladder for storage between meals. In chickens, the gallbladder is a pearshaped sac, 2 to 5 cm in length, and lies with its blind end opposite the caudal edge of the liver. When the gallbladder contracts, bile is forced into the cystic duct, which empties into the duodenum distal to the insertions of the left hepatic duct and the pancreatic ducts.
Tissue Preparation
Chickens were fasted overnight to ensure that plasma NT and CCK concentrations were basal. At the beginning of each experiment, the birds were euthanized by cervical dislocation, and gallbladders were removed and placed immediately in ice-cold Tyrode's buffer, which was continuously gassed with 5% CO 2 in 95% O 2 . Strips of circular smooth muscle (2 mm × 10 mm) were tied at the ends with surgical thread and suspended isometrically in isolated organ tissue baths maintained at 38°C and bubbled under a resting tension of 1.96 mN. Buffer was changed every 15 min for 1 h before experiments began. At the beginning of each experiment, 10 μM carbachol was added to test the reactivity of the preparations. Discrete concentration-response tests using 0.25, 0.5, 1.0, 1.5, 2, 5, 10, 30, 50, 100, and 300 nM peptide were performed at 10-min intervals separated by multiple washes in between. Contractions were recorded via force transducers that were connected to a 4-channel polygraph (model 79-D, Grass Instruments, Quincy, MA).
Drugs and Peptides
Avian NT has been isolated from the intestine of chickens and has a sequence similar to bovine NT (Carraway and Leeman, 1973) except for the substitution of His 3 , Val 4 , and Ala 7 for Tyr 3 , Glu 4 , and Pro 7 (Carraway and Bhatnagar, 1980) . The biologically active carboxy-terminus of the peptide is common to both species. Anesthetized rats given chicken NT (0.5 nmol/ mL per kg) exhibited similar physiological effects to those induced by bovine NT [i.e., hypotension, hyperglycemia, and cyanosis (Carraway and Bhatnagar, 1980) ]. Chicken NT also produced the same effects as bovine NT when applied to chicken rectal smooth muscle (Komori et al., 1986) . Therefore, bovine NT was used because it is commercially available and was purchased from Peninsula Laboratories (Belmont, CA). Neurotensin was solubilized in 0.1% BSA in 0.01 M acetic acid. The nonpeptide antagonist of the NTR1 antagonist, SR 48692, was obtained gratis from Sanofi Rechereche (Toulouse Cedex, France) and was solubilized in dimethyl sulfoxide.
Cholecystokinin octapeptide (CCK-8) was also purchased from Peninsula Laboratories and solubilized in distilled water containing a few drops of dilute acetic acid. The CCK-A antagonist lorglumide was purchased from Research Biochemicals Inc. (Sigma-RBI, Natick, ME) and dissolved in dilute methanol.
The cholinergic agonist carbachol (CCH) and the muscarinic cholinergic antagonist atropine sulfate were purchased from Peninsula Laboratories and dissolved in distilled water. Veratrine, a neuronal sodium channel activator, and tetrodotoxin (TTX), a selective axonal sodium channel blocker, were solubilized in methanol and ethanol, respectively. Nifedipine, a calcium channel blocker, was solubilized in dimethyl sulfoxide and experiments using it were conducted under low light conditions. These drugs were purchased from SigmaAldrich (St. Louis, MO).
Statistical Comparisons
Changes in contractile force (in mN) were observed and were determined from the baseline to the top of the treatment-induced response. Contractile responses were measured and means ± SEM were calculated for each concentration. Differences in responses among varying doses were statistically analyzed using ANOVA for multiple comparisons among means. Following the rejection of the null hypotheses that neither NT nor CCK-8 had any contractile effect on isolated strips of gallbladder, the Tukey-Kramer honestly significant difference test (JMP software, 2001 , SAS Institute Inc., Cary, NC) was used to determine which of the concentration responses were significantly different from each other. Additional concentration response data were analyzed with a computer software program designed by Tallarida and Murray (1981) .
RESULTS
Effect of NT on Gallbladder Contraction and Receptor Antagonism
Neurotensin (0.25-300 nM) induced concentrationdependent contractions on the circular smooth muscle of the gallbladder (Figure 1 ) with an EC 50 of 8.5 nM (95% confidence limits = 5.3-13.6 nM). The contractile effects of NT remained unaltered in tissues pretreated with10 μM atropine (P < 0.01, n = 3). Nevertheless, the effects of the cholinergic agonist carbachol were prevented by atropine at this concentration. Veratrine produced small changes in muscle tension that were inhibited by 0.1 μM TTX. The neurotoxin failed to alter the contractile actions of NT. The contractile response to NT was partially reduced by 0.1 μM nifedipine (69% of untreated tissues, P < 0.05, n = 4). The NTR1 antagonist SR 48692 (0.1 μM) did not produce a significant reduction in NT potency (Figure 2a ).
Effect of CCK-8 on Gallbladder Contraction and Receptor Antagonism
Cholecystokinin octapeptide (0.25-300 nM) also induced concentration-dependent contractions on the circular smooth muscle of the gallbladder (Figure 1 ) with an EC 50 of 13 nM (95% confidence limits of 9-20 nM). The contractile effects of CCK-8 remained unaltered in tissues pretreated with atropine, TTX, or nifedipine. The CCK-A antagonist, lorglumide, at a concentration of 1 μM, reduced the contractile potency of CCK-8 by one-half (Figure 2b ).
Comparing NT Contractile Responses to CCK-8
There were no statistical differences in contractile responses when comparing NT and CCK-8 at equimolar concentrations. Two additional gallbladder strips were used to determine if NT or CCK (at 10, 20, and 30 nM concentrations) had any potentiating or attenuating effect on each other after 2 min of incubation. In both cases, CCK-8 never elicited a contractile effect following a maximal contractile response to NT. However, NT always produced a contractile effect after a maximal contractile response to CCK-8.
DISCUSSION
The results of this study demonstrate that both NT and CCK-8 contract isolated circular smooth muscle of the gallbladder in vitro. Increased intestinal bile availability, as a result of increased bile flow, enhances the digestion and absorption of lipids in the intestine. Bile acids, the major component of bile, are capable of emulsifying lipids, resulting in more surface area for lipolytic enzyme activity. Bile acids can also form micelles with the products of lipid digestion and enhance fat transport and absorption across the brush-border of the intestine.
Neurotensin and CCK are both brain-gut peptides and they bind to different receptor types based on the selectivity of their ligands. Three subtypes of NT receptors have been cloned and functionally characterized. The NTR1 are expressed in brain and intestinal tissues and have a higher affinity for NT than the NTR2 localized primarily in brain tissue (Kitabgi et al., 1985) . The NTR3 is distributed in the brain and non-GI peripheral tissues (Vincent et al., 1999) . The NTR1 regulates gut motility and secretion (Vincent, 1995) . The CCK receptors have been broadly classified as CCKA (for alimentary) receptors and CCKB (for brain) receptors (Dourish and Hill, 1987) , although both receptors are expressed in various tissues of the central nervous system and the GI tract (Wank, 1995) .
To evaluate the actions of NT and CCK-8 on gallbladder contraction in chickens, we attempted to antagonize the specific actions of NT and CCK-8 at their cognate receptors and thus lessen or abolish their biological effects. The NTR1 antagonist SR 48692 (Gully et al., 1993) has been shown to inhibit NT binding to cloned rat and human NT receptors and antagonize NT-induced turning behavior in mice. Moreover, it inhibited hepatic bile flow in chickens (Gui et al., 2000) . On the other hand, SR 48692 failed to antagonize NTinduced hypothermic effects in rat and mice (Dubuc et al., 1994) , and at a concentration of 0.1 μM, we were unable to demonstrate a significant reduction in NT contractile potency in the present study ( Figure  2b) . Chicken NTR1 has a high sequence identity with its amphibian and mammalian counterparts (Numao et al., 2011) . We hypothesize that NT contractile effects in the chicken gallbladder that are resistant to SR 48692 may be mediated by an unconventional receptor pharmacologically distinct from NTR1, possibly the avian equivalent of NTR2 or NTR3 (Dubuc et al., 1994; Mazella and Vincent, 2006) .
Other studies of CCK on poultry have also demonstrated that mammalian-derived antagonists are ineffective in blocking CCK activity in avian preparations. For example, the CCK-8 actions on gastroduodenal motility and coordination in chickens could not be inhibited by either CCK-A receptor antagonist, L364,718, or CCK-B receptor antagonist, L365,260 (Martinez et al., 1993) . Pancreatic secretion induced in turkeys was also not blocked by the CCK-A receptor antagonist L364,718 (Campbell et al., 1991) . In contrast, CCK-8 induced suppression of food intake in white-crowned sparrows was inhibited by the CCKA receptor antagonist MK-329 (Richardson et al., 1993) .
Although the CCK-A antagonist lorglumide in our study did produce an increase in the EC 50 value for CCK-8 (Figure 2b) , the effect was small in comparison with that observed in mammalian studies. Increasing doses of lorglumide (0.2-6.5 μM) caused a rightward shift of the dose response curve for CCK-8 from an EC 50 of 8.2 nM ± 1.62 to an EC 50 of 100 nM ± 12 in guinea pig gallbladder strips and a shift from an EC 50 of 47 nM ± 8 to an EC 50 of 300 nM ± 10 in human gallbladder strips (Portincasa et al., 1990) . This phenomenon may be attributable to known pharmacological differences between avian and mammalian CCK receptors (Rodríguez-Sinovas et al., 1995) .
At equimolar concentrations, NT and CCK-8 evoked contractions in the chicken gallbladder isolated strips that were equivalent in magnitude. However, research with mammalian tissues has shown that NT and CCK actions on gallbladder contractions are species-specific. In canine gallbladder strips, the contractile responses to NT were less sensitive than those to CCK (Milenov et al., 1993) , possibly affirming a greater presence of CCK receptors in chicken gallbladder tissue. Neurotensin was ineffective in contracting rabbit gallbladder muscle strips (Guo et al., 1989) even though CCK-8 produced concentration-dependent contractions (Amer, 1972) . In isolated gallbladder strips from guinea pigs, NT induced concentration-dependent contractions (Guo et al., 1989; Milenov et al., 1993) . In similar studies, the NT-induced responses were reduced by tetrodotoxin (TTX) and atropine, and reversed by indomethacin, suggesting that some contractile activity may be via prostaglandin synthesis (Yamasato and Nakayama, 1988) . Neurotensin also induced concentration-dependent contractions in canine gallbladder strips. These responses were not modified by TTX, indicating that NT mediates at least some of its contractile effects by directly acting on smooth muscle (Guo et al., 1989) . No contraction or relaxation was observed in human isolated gallbladder strips (Guo et al., 1989) .
The mechanisms whereby NT and CCK evoke their gallbladder contractile actions may depend on whether data are collected from isolated tissues or intact organisms. In vivo studies using strain gauge force transducers to monitor canine contractile activity following bolus injections of NT or CCK (equivalent to endogenous release) showed the resulting gallbladder contractions to be very similar. In contrast to some in vitro studies, cholinergic pathways likely mediate these responses because both were abolished by atropine (Fujimura et al., 1994) . Work by Milenov et al. (1993) also observed similar results when conscious dogs were given NT and CCK-8 intravenously. Both NT and CCK-8 induced gallbladder pressures that were increased in a dose-dependent manner were inhibited by atropine or hexamethonium. In contrast, Walker et al. (1985) , using ultrasonography in humans, reported that sustained infusion of NT produced a gradual, steady dilatation of the gallbladder.
It can be postulated that NT functions in concert with CCK to promote the digestion and absorption of lipids. Cholecystokinin is a 33 amino acid brain-gut peptide (Thorpes and Mutt, 1973; Dockray, 1976; Rehfeld et al., 1979) . Intestinal CCK is produced by open enteroendocrine I cells of the proximal intestine (Buffa et al., 1976) , and its primary stimulus for release is also the presence of long-chain fatty acids, as well as amino acids (Meyer, 1975) . Cholecystokinin activity in vertebrate digestion is well documented; in addition to being a potent contractor of the gallbladder (Ivy and Oldberg, 1928; Schjoldager, 1994) , CCK is a stimulus for pancreatic activity (Harper and Raper, 1943) and has been shown to mediate relaxation of the stomach, resulting in a delay in gastric emptying in humans (Raybould and Tache, 1988; Liddle et al., 1989; Fried et al., 1991; Young et al., 1996; Schwizer et al., 1997) .
In conclusion, NT contracts the isolated circular smooth muscle of the gallbladder as effectively at CCK-8. Our results clearly indicate that avian receptors for NT and CCK-8 differ in their ability to bind antagonists in comparison with their mammalian counterparts. Neither SR 48692 nor lorglumide completely antagonized the action of NT or CCK-8, respectively, on the gallbladder. Thus, the actions of the 2 peptides are mediated through avian receptors that may differ pharmacologically from their mammalian counterparts and are differentially dependent upon extracellular Ca 2+ . As with NT-and CCK-induced gallbladder contractions in mammalian models, NT and CCK may have a common physiological role in the postprandial regulation of lipid digestion in chickens.
